<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Assesment 1</title>
    <link rel="stylesheet" href="./css/stylesheet.css" />
  </head>
  <body>
    <header>
      <a href="#">Menu</a>
      <img src="./img/logo_2.svg" alt="Logo Safety Observe" />
      <a href="#" class="carrito"
        >0<img src="./img/shopping-cart.png" alt="Shopping Cart"
      /></a>
    </header>
    <nav>
      <img src="./img/logo.svg" alt="Safety observer Logo" />
      <ul>
        <li>Home</li>
        <li>Plans</li>
        <li>News</li>
        <li>Assistance</li>
      </ul>
      <a href="#">Login</a>
      <button>Sign up for alerts</button>
      <a href="#" class="carrito"
        >0<img src="./img/shopping-cart.png" alt="Shopping Cart"
      /></a>
    </nav>
    <main>
      <section>
        <h1>Regulatory Intelligence, straight to your mailbox</h1>
        <p>
          Stay on top of Human Phamacovigilance requirements with our monthly
          Regulatory Intelligence Reports.
        </p>
        <div>
          <button class="blueButton">Sign up for alerts</button>
          <button>View Plans</button>
        </div>
      </section>
      <div>
        <ul>
          <li>
            <img class="checkmarkAzul" src="./img/check.png" />Monthly reports
          </li>
          <li>
            <img class="checkmarkAzul" src="./img/check.png" />Subscription
            plans
          </li>
          <li>
            <img class="checkmarkAzul" src="./img/check.png" />Over 70 Pharma &
            Biotech clients
          </li>
          <li>
            <img class="checkmarkAzul" src="./img/check.png" />Over 3,000 users
          </li>
        </ul>
      </div>
      <section>
        <article class="lastReport">
          <img src="./img/coverweb_187.jpg" alt="Cover of Report 187" />
          <h5>Latest report March 2022</h5>
          <h3>Safety Observer 187</h3>
          <p>
            The EMA has revised its RMP guidance for COVID-19 vaccines with
            updated requirements for Summary Safety Reports.
          </p>
          <ul>
            <li><span class="bold">Released</span> 09-Mar-2022</li>
            <li><span class="bold">Pages</span> 29</li>
          </ul>
          <div>
            <button class="blueButton">Buy - 72€</button>
            <button class="greyButton">Highlights</button>
          </div>
        </article>
      </section>
      <section class="pastReport">
        <h2>Past Reports</h2>
        <article>
          <img src="./img/coverweb_186.jpg" alt="Cover of Report 186" />
          <h5>February 2022</h5>
          <h3>Safety Observer 186</h3>
          <p>
            The new EU Clinical Trial Regulation became applicable as the CTIS
            went love on 31-Jan-2022
          </p>
          <div>
            <button class="blueButton">Buy - 72€</button>
            <button class="greyButton">Highlights</button>
          </div>
        </article>
        <article>
          <img src="./img/coverweb_185.jpg" alt="Cover of Report 187" />
          <h5>February 2022</h5>
          <h3>Safety Observer 185</h3>
          <p>
            Both the US FDA and the MHRA have published new guidance to promote
            the use of RWD in clinical trials.
          </p>
          <div>
            <button class="blueButton">Buy - 72€</button>
            <button class="greyButton">Highlights</button>
          </div>
        </article>
        <article>
          <img src="./img/coverweb_184.jpg" alt="Cover of Report 187" />
          <h5>December 2021</h5>
          <h3>Safety Observer 184</h3>
          <p>
            The FDA has published a new draft guidance that provides
            considerations for the ise of registries
          </p>
          <div>
            <button class="blueButton">Buy - 72€</button>
            <button class="greyButton">Highlights</button>
          </div>
        </article>
      </section>
      <section class="plansSection">
        <div>
          <h2>3-Month Plan</h2>
          <p>
            This Plan includes three consecutive reports starting with the next
            release. The perfect solution to test the value of service.
          </p>
          <h3>Start at 180€</h3>
          <ul>
            <li>3 Regulatory Intelligence Reports</li>
            <li>Volume pricing avaliable</li>
            <li>16% OFF</li>
          </ul>
          <button>Buy 3-Month Plan</button>
          <button>More info</button>
        </div>
        <div>
          <h2>1-Year Plan</h2>
          <p>
            This Plan includes eleven consecutive reports starting with the next
            release. Includes a double issue for July/August.
          </p>
          <h3>Start at 600€</h3>
          <ul>
            <li>11 Regulatory Intelligence Reports</li>
            <li>Volume pricing avaliable</li>
            <li>24% OFF</li>
          </ul>
          <button>Buy 1-Year Plan</button>
          <button>More info</button>
        </div>
      </section>
      <section>
        <h2>Latest News</h2>
      </section>
      <section class="beforeFooter">
        <h3>Supporting the global Pharmacovigilance commmunity since 2005</h3>
        <p>
          We are proud to serve pharmacovigilance professionals in more than 100
          organisations across the world, including major phar corporations,
          small biotech, service providers, and public hospitals.
        </p>
        <button>About us</button>
      </section>
    </main>
    <footer>
      <img src="./img/logo_2.svg" alt="Logo Safety Oberver" />
      <p>Safety Observer, 2005-2021</p>
      <ul>
        <li><a href="#"></a>Legal</li>
        <li><a href="#"></a>LinkedIn</li>
        <li><a href="#"></a>Twitter</li>
      </ul>
    </footer>
  </body>
</html>
